HOME > > Products > PRONULIFE® (Probiotic) > PRONULIFE® GasProtect / GasProtect-M
PRONULIFE® GasProtect / GasProtect-M
Targeted Solutions for Upper GI Comfort and Gastric Microbiota Balance
Global Burden of Gastric Health Challenges
More than 4.4 billion people worldwide are infected with Helicobacter pylori, accounting for over half the global population. This bacterium is a major causative agent of chronic gastritis, peptic ulcers, and gastric cancer, with particularly high prevalence in Asian countries.
Infected individuals face a 6–10× higher risk of developing gastric cancer. Additionally, over 3 billion people are estimated to suffer from chronic gastritis, closely linked to upper GI dysbiosis.
Formulation Objectives of PRONULIFE® GasProtect
PRONULIFE® GasProtect is formulated to deliver daily support for upper GI health and microbial balance. By leveraging synergistic effects of selected probiotic strains, it helps maintain digestive comfort and mucosal defense.
All strains are patent-registered and produced in our own GMP-certified facility to ensure consistent quality and long-term viability.
Key Benefits
✅ Supports balanced gastric microbiota and mucosal barrier integrity
✅ Helps relieve upper abdominal discomfort and postprandial unease
✅ Protected by international patents and supported by functional research
✅ Suitable for daily supplements or advanced formulation integration
Patents
📩 For technical data, customization inquiries, or formulation partnerships, contact us at
📧 glac@glac.com.tw
Further Reading: PRONULIFE® Functional Probiotic Ingredients🔙
Global Burden of Gastric Health Challenges
More than 4.4 billion people worldwide are infected with Helicobacter pylori, accounting for over half the global population. This bacterium is a major causative agent of chronic gastritis, peptic ulcers, and gastric cancer, with particularly high prevalence in Asian countries.
Infected individuals face a 6–10× higher risk of developing gastric cancer. Additionally, over 3 billion people are estimated to suffer from chronic gastritis, closely linked to upper GI dysbiosis.
Formulation Objectives of PRONULIFE® GasProtect
PRONULIFE® GasProtect is formulated to deliver daily support for upper GI health and microbial balance. By leveraging synergistic effects of selected probiotic strains, it helps maintain digestive comfort and mucosal defense.
- Multi-strain formulation designed to regulate the gastric microbiot
- Demonstrated inhibition of pathogenic adhesion and growth
- Supports mucosal barrier integrity and improves daily digestive resilience
Formulation Information
| Product | Probiotic Strains |
| PRONULIFE® GasProtect | Lactobacillus salivarius AP-32 Lactobacillus rhamnosus F-1 Lactobacillus plantarum LPL28 |
| PRONULIFE® GasProtect-M | Lactobacillus johnsonii MH-68 Lactobacillus salivarius AP-32 Lactobacillus rhamnosus F-1 Lactobacillus acidophilus TYCA06 |
Key Benefits
✅ Supports balanced gastric microbiota and mucosal barrier integrity
✅ Helps relieve upper abdominal discomfort and postprandial unease
✅ Protected by international patents and supported by functional research
✅ Suitable for daily supplements or advanced formulation integration
Patents
- TWI384990｜Application of Lactobacillus strains in food/pharmaceutical compositions for promoting gastric comfort
- ZL 201110179109.2 (CN102835666B)｜Use of Lactobacillus strains in gastric-targeted formulations
📩 For technical data, customization inquiries, or formulation partnerships, contact us at
📧 glac@glac.com.tw
